You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NF1-associated glioma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neurofibromatosis Type 1, Plexiform Neurofibroma, Optic Nerve Glioma Trial in London (Selumetinib)

Recruiting
  • Neurofibromatosis Type 1
  • +2 more
  • London, United Kingdom
  • +1 more
Nov 11, 2021

Low Grade Glioma (LGG) of Brain With BRAF Aberration, High Grade Glioma (HGG) of the Brain With BRAF Aberration, Low Grade

Recruiting
  • Low Grade Glioma (LGG) of Brain With BRAF Aberration
  • +2 more
  • Phoenix, Arizona
  • +12 more
Apr 7, 2022

Neurofibromatosis Type 1, Plexiform Neurofibromas, Post-operative Trial in Beijing, Shanghai (Selumetinib, Placebo)

Not yet recruiting
  • Neurofibromatosis Type 1
  • +2 more
  • Beijing, China
  • +2 more
Apr 11, 2023

NF1, Low-grade Glioma Trial in United States (Poly ICLC)

Recruiting
  • NF1
  • Low-grade Glioma
  • Poly ICLC
  • Birmingham, Alabama
  • +18 more
Jan 5, 2023

Low Grade Glioma, Neurofibromatosis Type 1, Visual Pathway Glioma Trial in Canada, Puerto Rico, United States (Carboplatin,

Recruiting
  • Low Grade Glioma
  • +2 more
  • Birmingham, Alabama
  • +120 more
Jan 27, 2023

Grade 1 Glioma, Mixed Glio-neuronal Tumors, Pleomorphic Xanthoastrocytoma Trial in Strasbourg (Trametinib, Vinblastine)

Recruiting
  • Grade 1 Glioma
  • +2 more
  • Strasbourg, France
    CHU Strasbourg - France
Jul 7, 2022

Cutaneous Neurofibroma Trial in New York (DPCP)

Not yet recruiting
  • Cutaneous Neurofibroma
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jun 24, 2022

Glioma Trial in United States

Recruiting
  • Glioma
    • Basking Ridge, New Jersey
    • +6 more
    Aug 3, 2022

    PET/MRI in CNS and Extra-CNS Tumors of Neurofibromatosis-1 (NF1)

    Completed
    • Neurofibromatosis-1
    • +2 more
      • Chapel Hill, North Carolina
        University of North Carolina-Chapel Hill
      May 11, 2021

      Epilepsy; Seizure Trial (ES-481)

      Withdrawn
      • Epilepsy; Seizure
      • (no location specified)
      Mar 28, 2022

      Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

      Recruiting
      • Refractory Cancer
      • +14 more
      • Atlanta, Georgia
      • +1 more
      Oct 23, 2023

      Low-grade Glioma, Plexiform Neurofibroma, CNS Glioma Trial in Canada (Trametinib)

      Active, not recruiting
      • Low-grade Glioma
      • +2 more
      • Calgary, Alberta, Canada
      • +6 more
      Oct 25, 2022

      Plexiform Neurofibroma, Neurofibromatosis Type 1 (NF1) Trial in United States (Mirdametinib (PD-0325901) oral capsule or

      Active, not recruiting
      • Plexiform Neurofibroma
      • Neurofibromatosis Type 1 (NF1)
      • Mirdametinib (PD-0325901) oral capsule or dispersible tablet
      • Birmingham, Alabama
      • +49 more
      Nov 17, 2022

      Recurrent Low Grade Astrocytoma, Recurrent WHO Grade 2 Glioma, Refractory Low Grade Astrocytoma Trial in Canada, United States

      Recruiting
      • Recurrent Low Grade Astrocytoma
      • +4 more
      • Quality-of-Life Assessment
      • +3 more
      • Birmingham, Alabama
      • +64 more
      Aug 20, 2022

      Frameshift Peptides of Children With NF1

      Completed
      • Neurofibromatosis Type 1
      • Frameshift Array blood sample test
      • Washington, District of Columbia
      • +2 more
      Aug 29, 2022

      Neurofibromatosis Type 1, Plexiform Neurofibroma Trial in United States (Binimetinib)

      Active, not recruiting
      • Neurofibromatosis Type 1
      • Plexiform Neurofibroma
      • Birmingham, Alabama
      • +21 more
      Dec 4, 2021

      Optic Pathway Glioma Trial in Rome (CHF6467, Placebo)

      Not yet recruiting
      • Optic Pathway Glioma
      • Rome, Italy
        Catholic University, Policlinico A. Gemelli (Hospital)
      Feb 17, 2023

      Neurofibromatosis 1 Trial in Baltimore, Redwood City

      Recruiting
      • Neurofibromatosis 1
        • Baltimore, California
        • +1 more
        Aug 17, 2022

        Stressors in Parents of Cancer or Neurofibromatosis Type 1 (NF1)

        Completed
        • Parents of Children With Cancer
        • +2 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 26, 2023

          Disfigurement From Photographs of Neurofibromatosis Type 1

          Completed
          • Neurofibromatosis 1
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Jan 20, 2023

            Biology of Skin Neurofibromas in Neurofibromatosis Type 1

            Completed
            • Neurofibromatosis Type 1
            • Neurofibroma
              • Bethesda, Maryland
                National Institutes of Health Clinical Center
              Jan 20, 2023

              Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)

              Not yet recruiting
              • Recurrent High Grade Glioma
              • +4 more
              • (no location specified)
              Jan 24, 2023

              Stem Cells in NF1 Tumors of the Central Nervous System

              Suspended
              • Neurofibromatosis Type 1
              • Tumors of the Central Nervous System
              • Collection of Stem Cells
              • Washington, District of Columbia
                Children's National Medical Center
              Mar 8, 2022

              Malignant Peripheral Nerve Sheath Tumors, Neurofibromatosis 1 Trial in United States (Selumetinib, Sirolimus)

              Active, not recruiting
              • Malignant Peripheral Nerve Sheath Tumors
              • Neurofibromatosis 1
              • Washington, District of Columbia
              • +4 more
              Apr 1, 2022

              Glioma, Malignant Trial in Durham (Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine, Hiltonol)

              Not yet recruiting
              • Glioma, Malignant
              • Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine
              • Hiltonol
              • Durham, North Carolina
                The Preston Robert Tisch Brain Tumor Center at Duke University
              Jan 19, 2023